Explore our insights

In Q2 2026, pharma and healthcare deal activity reflected a selective investment environment. Strategic acquisitions, portfolio strengthening and capability-led expansion remained key themes across the sector.

Delhi has built one of India’s most advanced healthcare ecosystems, serving over two crore residents and acting as a leading referral hub for tertiary and quaternary care across North India.

The consumer and retail sector witnessed sustained investment interest as businesses strengthened category leadership, expanded portfolios and pursued differentiated growth opportunities.

Healthcare worker safety in India has emerged as one of the most pressing challenges facing the country's healthcare system.

India likes to tell itself a comforting story: that it is a young nation and will remain so for decades. But demographics do not bend to narrative.

Pharma and healthcare deal activity in Q1 2026 reflects steady volumes alongside a more measured approach to capital deployment.

India stands at a decisive inflection point in the evolution of healthcare in India. Over the past decade, the country has built healthcare access at population scale through landmark reforms such as Ayushman Bharat, expanded public health financing, and the creation of a nationally interoperable digital health infrastructure India.

India’s economic transformation has reached an inflection point where physical infrastructure, capital markets, and real estate converge to power the next era of high-quality growth.

Union Budget 2026 signals a decisive pivot in India’s health policy to build the full stack required for an innovation-led, patient-centred health economy.

Digital transformation in Indian healthcare explores how hospitals are adopting technology to improve care delivery, operational efficiency and patient experience, with digital infrastructure, EMRs, interoperability and AI emerging as key enablers and challenges in the sector.

Union Budget 2026 should shift India’s health system from hospital-centric treatment to prevention-led care by boosting primary health services, mission-mode NCD and cancer screening, mental health programmes, frontline health workforces and cross-sector public health interventions for long-term resilience and productivity.

India’s healthcare and pharma sector saw strong growth powered by investments, policy reforms, digital health and AI-driven innovation.

India and Japan have evolved their relationship into a strong, strategic partnership focused on shared growth and prosperity. This alliance is built on a foundation of economic collaboration, cultural resonance, spiritual connection, and centuries-old civilisational ties. Together, the two nations have made significant strides in navigating the challenges of globalisation and technological change, further deepening their mutual bond.

The Bihar healthcare sector is poised to become a key driver of state GDP growth, employment, and social progress. As Bihar targets a trillion-dollar economy by 2047, healthcare can do far more than treat illness. It can expand productive years, reduce out-of-pocket (OOP) spending, catalyse local manufacturing, and professionalise services across an integrated healthcare economy.

GST overhaul cuts tax on medicines & devices, making healthcare affordable. Pharma and medtech must realign pricing, supply chains, and innovation to drive access and growth.

Discover how Delhi’s healthcare system is evolving, insights from Grant Thornton Bharat on infrastructure gaps, investment needs, and policy focus.